Related Experiment Video

Updated: Jul 3, 2026

Procedures for the Identification of SARS-CoV-2 Entry Inhibitors as Potential Antivirals using MLV-Based Pseudoviruses
11:43

Procedures for the Identification of SARS-CoV-2 Entry Inhibitors as Potential Antivirals using MLV-Based Pseudoviruses

Published on: February 27, 2026

Development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3CL(pro)

Usman Bacha1, Jennifer Barrila, Sandra B Gabelli

  • 1Department of Biology, The Johns Hopkins University, Baltimore, MD 21218, USA.

Chemical Biology & Drug Design
|July 10, 2008
PubMed

Insights

Researchers developed potent broad-spectrum antiviral inhibitors targeting the conserved main protease (3CLpro) in coronaviruses. These novel halomethyl ketone compounds show high affinity and provide a promising strategy for combating diverse coronavirus infections.

Area of Science:

  • Virology
  • Medicinal Chemistry
  • Structural Biology

Background:

  • Coronaviruses are a diverse group of RNA viruses known for high mutation rates, enabling cross-species transmission and emergence of pathogenic strains like SARS-CoV.
  • The conservation of the main protease (3CLpro or Mpro) across all coronaviruses presents a viable target for developing broad-spectrum antiviral therapies.
  • Existing antiviral strategies necessitate the development of agents effective against multiple coronavirus species due to their adaptability.

Purpose of the Study:

  • To identify and characterize a new class of broad-spectrum antiviral inhibitors targeting the highly conserved 3CLpro of coronaviruses.
  • To design and synthesize novel compounds with a halomethyl ketone warhead aimed at inhibiting 3CLpro activity.
  • To elucidate the binding mechanism and structure-activity relationships (SAR) of these inhibitors for optimized therapeutic potential.

Main Methods:

  • Utilized severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro as the primary target for inhibitor screening and design.
  • Synthesized a series of halomethyl ketone-containing compounds and evaluated their inhibitory potency against SARS-CoV 3CLpro.
  • Determined the crystal structure of a 3CLpro-inhibitor complex to understand the molecular interactions and binding mode.
  • Conducted Structure-Activity Relationship (SAR) studies to identify key molecular features for high-affinity binding.

Main Results:

  • Identified a novel class of inhibitors containing a halomethyl ketone warhead with high potency against SARS-CoV 3CLpro, exhibiting inhibition constants (Ki) as low as 300 nM.
  • The crystal structure revealed that the inhibitor forms a covalent thioether linkage with the catalytic Cysteine 145 residue of 3CLpro.
  • SAR studies successfully defined a pharmacophore model, outlining the essential structural requirements for high-affinity inhibition of the target protease.

Conclusions:

  • The developed halomethyl ketone inhibitors represent a promising new class of broad-spectrum antivirals against coronaviruses.
  • Targeting the conserved 3CLpro with these rationally designed inhibitors offers a viable strategy for developing effective treatments for diverse coronavirus infections.
  • The identified pharmacophore provides a foundation for further optimization and development of potent coronavirus therapeutics.

More Related Videos

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation07:53

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation

Published on: January 9, 2019

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...